!['Last Mile' Initiative Overview](/sites/default/files/styles/full_page_width_max_width_100_/public/2023-08/Last-Mile-Initiative-Overview.png?itok=72dC2VhX)
NCI Cervical Cancer ‘Last Mile’ Initiative (LMI)
Goal: Overcome barrier of lack of FDA approval for self-collection approaches for HPV testing-based cervical cancer screening
Approach: Engage public and private sector stakeholders to facilitate regulatory approvals for self-collection
Outcome: Increase screening access and reduce cervical cancer incidence in underserved and high-burden populations